BioNxt Solutions (TSE:BNXT) has released an update.
BioNxt Solutions has successfully closed its third tranche of a private placement, raising a significant $1.4 million through convertible debentures, bringing the total raised to $2.11 million. The funds will support product development, intellectual property filings, and general working capital. Investors may find this move attractive due to the debentures’ 8% annual interest and potential conversion to common shares.
For further insights into TSE:BNXT stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com